Ultimo aggiornamento :
11/06/2021
Stabilità e compatibilità dei farmaci
Benvenuti su Stabilis. Se desiderate ricevere la nostra newsletter trimestrale vi preghiamo di indicare il vostro indirizzo e-mail. Iscriviti

Per qualsiasi domanda o osservazione, contattare : infostab@stabilis.org
Banche di dati  
Bibliografia : 2647
Molecola : 811
Classe farmacologica : 46
Stabilità delle soluzioni : 5894
Stabilità come miscela : 1187
Compatibilità : 11838
Nome commerciale : 4523
Notizie - Molecola  
Farmaco contro il cancro Iniezione Gemtuzumab ozogamicin 03/06/2021
Ormone Unguenti Estrone 03/06/2021
Ormone Unguenti Progestérone 03/06/2021
Ormone Unguenti Testostérone 03/06/2021
Farmaco contro il cancro Iniezione Pemetrexed diarginine 03/06/2021
Ormone Unguenti Estradiol 01/06/2021
Antipertensivo Soluzione orale Nicardipine hydrochloride 26/05/2021
Anticoagulante Iniezione Nafamostat 19/04/2021
Ormone Iniezione Thiamazole 09/03/2021
Ansiolitico Capsula Midazolam hydrochloride 03/03/2021
Altro Iniezione Turoctocog alfa 03/03/2021
Antibiotico Iniezione Cefiderocol sulfate tosylate 03/03/2021
Antiaritmico Iniezione Flecainide acetate 04/12/2020
Antibiotico Iniezione Cefotiam 04/12/2020
Altro Soluzione orale Carbimazole 01/12/2020
Farmaco contro il cancro Iniezione Durvalumab 25/11/2020
Antibiotico Iniezione Imipenem-Cilastatin / Relebactam 12/11/2020
Farmaco contro il cancro Iniezione Avelumab 04/11/2020
Antibiotico Iniezione Meropenem Vaborbactam 06/09/2020
Antalgico Iniezione Dezocine 05/09/2020
Notizie - Bibliografia  
Data di entrata
4578 Etude de stabilité de médicaments anticancéreux injectables : apports analytiques et pharmaceutiques 12/05/2021
4579 Application of the HPLC Method in Parenteral Nutrition Assessment: Stability Studies of Ondansetron Processes 12/05/2021
4575 Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt. Int J Pharm Compound 06/05/2021
4576 Stability of Extemporaneously-compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes. Int J Pharm Compound 06/05/2021
4577 Stability of Fagron's Phytobase Cream Compounded with Various Hormones. Int J Pharm Compound 06/05/2021
4572 Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures. Antibiotics 04/05/2021
4571 Levosimendan (Simdax 2.5 mg/ml) - Summary of Product Characteristics Orion Pharma 19/04/2021
4568 Long-term physico-chemical stability of 5-fluorouracile at standardised rounded doses (SRD) in MyFuser® portable infusion pump. Journal of Chemotherapy 13/04/2021
4569 Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications. Hosp Pharm 13/04/2021
4570 Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients. Pharmaceuticals 13/04/2021
4567 Addition of Regular Insulin to Ternary Parenteral Nutrition: A Stability Study. Pharmaceutics 08/04/2021
4561 New liquid oral formulations of hydroxychloroquine: a physicochemical stability study. Pharmaceutical Technology in Hospital Pharmacy 07/04/2021
4563 Stability study of a compounded oral solution of nicardipine for the treatment of hypertension in children. Eur J Pharm Sci 07/04/2021
4556 The Physical Compatibility of Clinically Used Concentrations of Diltiazem Hydrochloride With Heparin Sodium. J Pharm Technol 24/03/2021
4559 Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration. Drug Design Dev Ther 24/03/2021
4546 Stability of pemetrexed diarginine concentrates for solution in vials and diluted in 0.9% sodium chloride and dextrose 5% polyolefin infusion bags. EJHP 23/03/2021
4548 Intravenous Compatibility of Ceftazidime/Avibactam and Aztreonam Using Simulated and Actual Y-site Administration. Clin Ther 23/03/2021
4550 The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration. Crit Care Resusc 23/03/2021
4545 Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment. Journal of Nippon Medical school 22/03/2021
4538 Compatibility of pentoxifylline and parenteral medications. Archives of Disease in Childhood 19/03/2021
4532 Atezolizumab (Tecentriq®) - Summary of Product Characteristics Roche Products Limited 25/02/2021
4529 Arsenic trioxide - Summary of Product Characteristics Accord Healthcare S.L.U. 23/02/2021
4528 Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 12/02/2021
4526 Stability of mitomycin in polypropylene syringes for use in glaucoma surgery. EJOP 02/02/2021
4525 Evaluation of the Physico-Chemical and Biological Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions. Adv Ther 28/01/2021
4523 Formulation and stability study of hydroxychloroquine sulfate oral suspensions. Pharm Dev Technol 20/01/2021
4524 Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology. ESCP Symposium, Geneva, Switzerland 20/01/2021
4522 Six months stability investigation of sufentanil and ropivacaine/levobupivacaine admixtures in plastic container by LC-UV. J Pharm Biomed Anal 19/01/2021
4521 Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Pharmaceutical Technology in Hospital Pharmacy 12/01/2021
4518 In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion. EJHP 06/01/2021

  Mentions Légales